Feetsee Inc.

👣 Understanding the Signs: How Diabetes Affects Your Feet Did you know that diabetes can lead to complications in your feet that are often overlooked? Nerve damage, poor circulation, and unnoticed injuries are just some of the ways diabetes can quietly impact your foot health. At Feetsee, we’re committed to empowering individuals with knowledge and tools to prevent these complications. Our latest article dives into: 1. Early warning signs of diabetic foot issues 2. The connection between neuropathy and foot ulcers 3. Practical tips to maintain foot health Your feet deserve care and attention! Whether you’re managing diabetes or supporting a loved one, understanding these symptoms can make a world of difference. 🔗 Read the full article here: https://lnkd.in/dNiPtw4Y Let’s take a step toward healthier feet together! 🦶💙 #DiabetesCare #FootHealth #HealthTech #Feetsee

Our team was honored to participate in World Diabetes Day 2024 at Santaros Clinics, organized by the Center of Endocrinology, Vilnius University Hospital Santaros Klinikos. We showcased Feetsee, our solution for early detection of diabetic foot ulcers, and connected with inspiring professionals dedicated to advancing diabetes care. Grateful for the opportunity to contribute to this important cause! 💙 #WorldDiabetesDay #Feetsee #DiabetesCare #HealthcareInnovation #DFU #DiabeticFootUlcer #PeripheralNeuropathy

This month, we’re excited to participate in DFCon24 in Los Angeles—the premier global conference dedicated to diabetic foot ulcer and amputation prevention. Being part of this field and contributing to solutions that improve health outcomes worldwide is truly rewarding.

Proud to share that Feetsee recently participated in the EIT Health InnoStars Awards Investment Track bootcamp in Vienna! Over four days, we gained insights to refine our investment strategy and strengthen Feetsee’s growth in health tech. It was nice to catch up with other industry founders from the EU. #HealthTech #Innovation #EITHealth #InnoStars #Feetsee #MedTech #Diabetes #DiabeticFootUlcer #EuropeanInnovation

🎉 We’re thrilled to announce that Feetsee has been selected as a finalist in the 2024 EIT Health InnoStars Awards! 🎉 This recognition places us among the top 20 innovative teams in the Investment Track, highlighting our dedication to improving diabetic foot care with advanced technology. The InnoStars Awards is a prestigious program aimed at supporting healthcare startups that show high potential for positive impact, and we are honored to be part of this journey. 🌟 Feetsee’s mission is to empower individuals with diabetes by providing a simple and effective monitoring device to help detect diabetic foot ulcers (DFU) early, reducing complications and improving quality of life. Our participation in the upcoming bootcamps will help us refine our approach as we look to attract investment and grow our impact. 🌍 We want to extend our sincere thanks to EIT Health for believing in our vision, and we congratulate all the other finalists who are helping shape the future of healthcare. Stay tuned for more updates 📢 as we move forward in this exciting chapter! —The Feetsee Team

Last week, we had the pleasure of visiting Chicago to meet with our amazing partners and attend the American Medical Device Summit. It was a great opportunity to connect with key industry players, exchange insights, and learn about the latest trends shaping the future of medical technology. 💡 We’re excited to bring these insights back to Feetsee Inc. as we continue innovating solutions for early diabetic foot ulcer detection. #MedTech #Innovation #Healthcare #Feetsee #MedicalDevices #DiabeticCare #DiabeticUlcer #DiabeticFootUlcer #FootCare

We are thrilled to announce that we have been selected to join the prestigious UCLA Global Access Program (GAP). This exciting opportunity allows us to work closely with the talented MBA students from UCLA Anderson School of Management over the next six months.   Together, we are embarking on a comprehensive market entry program focused on our groundbreaking Feetsee product, which has the potential to save millions of lives of people living with diabetes. The program involves in-depth market research, strategic planning, and practical implementation strategies to ensure successful entry into the market.

Yet again we are thrilled to announce that DIABETIS JSC has successfully secured funding from the plan "New Generation Lithuania" which is financed under the European Union economic recovery and resilience facility instrument NextGenerationEU. 🎉 The aim of our new project is to develop a proof of concept of the thermographic product “ArtiSee” which is intended to be used for determining signs of inflammation in patients with arthritis. The “ArtiSee” system would be designed to detect early signs of joint inflammation, helping to identify and diagnose rheumatoid arthritis earlier. Also, ArtiSee is intended to be used as a tool to help arthritis patients self-examine their joints and monitor the course of the disease, react earlier to flare-ups, and personalize treatment. 💡🔬ArtiSee would be a new tool for clinical practice, helping to detect signs of inflammation earlier than the human eye can see. The ARtiSee project is slated to span from June 2024 to December 2024.

📢 Exciting news! 🌟 We are happy to announce that a new project with our Feetsee device is starting at the Santaros Diabetes Clinic. The feet of diabetic patients will be scanned and thousands of thermal images will be used to improve the Feetsee algorithm. 🔍 Feetsee aims to revolutionize diabetic foot care, and we are continuing this journey at the Santara Diabetes Clinics to make a real impact. Stay tuned for updates as we launch Feetsee soon! 🚀   #DiabeticFoot #Santaros #FeetSee #Diabetes #startup